The challenge of drug-induced aseptic meningitis revisited

JAMA Internal Medicine

Volumn 174, Issue 9, 2014, Pages 1511-1512

  Morís, German ^a   Garcia Monco, Juan Carlos ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; ANTIINFECTIVE AGENT;

ASEPTIC MENINGITIS; DISEASE DURATION; DRUG EXPOSURE; DRUG INDUCED ASEPTIC MENINGITIS; HUMAN; KIDNEY GRAFT; LETTER; NEUROIMAGING; SYSTEMATIC REVIEW; CEREBROSPINAL FLUID; CHEMICALLY INDUCED;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MENINGITIS, ASEPTIC;

EID: 84907013296     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.2918     Document Type: Letter

References (6)

1. Morís G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999;159(11):1185-1194.
2. Simms KM, Kortepeter C, Avigan M. Lamotrigine and aseptic meningitis. Neurology. 2012;78(12):921-927.
3. Hegde N, Gayomali C, RichMW. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum? South Med J. 2005;98(5):564-566.
4. Kluger N, Girard C, Gonzalez V, Guillot B, Bessis D. Efalizumab-induced aseptic meningitis. Br J Dermatol. 2007;156(1):189-191.
5. Emani MK, Zaiden RA Jr. Aseptic meningitis: a rare side effect of cetuximab therapy. J Oncol Pharm Pract. 2013;19(2):178-180.
6. Shah BK, O'Keefe S. Pemetrexed-induced aseptic meningitis. Acta Oncol. 2012; 51(3):399-400.